Lindis Blood Care has taken up the challange of reducing the negative effects of donor blood administration during surgical tumor removal by developing and manufacturing a new medical device that allows the save retransfusion of patients own blood.
Lindis Blood Care removes cancer cells from patient´s intraoperative blood for retransfusion. For that purpose we are developing the medical device, CATUVAB®
CATUVAB® is intended to be used as an add on in combination with the best practice methods.
Our patented technology CATUVAB® is based on inducing cell complexes with tumor cells and removing them by centrifugation and filtration by involving technical equipment (IBS device) that is currently available at nearly all hospitals.